Phibro Animal Health Corporation (NASDAQ:PAHC) had its price target raised by equities research analysts at Credit Suisse Group from $36.00 to $37.00 in a report released on Thursday. The firm currently has an “outperform” rating on the stock. Credit Suisse Group’s price target would indicate a potential upside of 1.37% from the company’s current price.

PAHC has been the topic of several other reports. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Thursday, May 11th. Bank of America Corporation reaffirmed an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Finally, Piper Jaffray Companies set a $42.00 price target on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a report on Friday, August 25th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $31.86.

Phibro Animal Health Corporation (NASDAQ PAHC) opened at 36.50 on Thursday. The company has a market capitalization of $1.45 billion, a PE ratio of 22.67 and a beta of 1.37. The company has a 50-day moving average price of $38.54 and a 200-day moving average price of $33.35. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The firm had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. During the same period in the previous year, the company earned $0.32 earnings per share. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. Analysts expect that Phibro Animal Health Corporation will post $1.54 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Credit Suisse Group Increases Phibro Animal Health Corporation (PAHC) Price Target to $37.00” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/credit-suisse-group-increases-phibro-animal-health-corporation-pahc-price-target-to-37-00/1537734.html.

In other news, major shareholder Bfi Co., Llc sold 48,000 shares of the stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $34.82, for a total transaction of $1,671,360.00. Following the sale, the insider now directly owns 96,000 shares of the company’s stock, valued at approximately $3,342,720. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Daniel M. Bendheim sold 4,976 shares of the stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $40.01, for a total transaction of $199,089.76. Following the sale, the vice president now directly owns 4,176 shares in the company, valued at $167,081.76. The disclosure for this sale can be found here. Over the last three months, insiders have sold 268,657 shares of company stock worth $9,802,503. Corporate insiders own 48.09% of the company’s stock.

Large investors have recently bought and sold shares of the company. Alps Advisors Inc. raised its stake in Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock valued at $650,000 after buying an additional 46 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock valued at $211,000 after buying an additional 100 shares during the last quarter. Arizona State Retirement System raised its stake in Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after buying an additional 100 shares during the last quarter. Nationwide Fund Advisors raised its stake in Phibro Animal Health Corporation by 1.0% in the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock valued at $403,000 after buying an additional 110 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan raised its stake in Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. 48.35% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Analyst Recommendations for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.